Identification of isocitrate dehydrogenase 1 as a potential diagnostic and prognostic biomarker for non-small cell lung cancer by proteomic analysis

Molecular and Cellular Proteomics

Volumn 11, Issue 2, 2012, Pages

  Tan, Fengwei ^a   Jiang, Ying ^b   Sun, Nan ^a   Chen, Zhaoli ^a   Lv, Yongzhuang ^b   Shao, Kang ^a   Li, Ning ^a   Qiu, Bin ^a   Gao, Yibo ^a   Li, Baozhong ^a   Tan, Xiaogang ^a   Zhou, Fang ^a   Wang, Zhen ^a   Ding, Dapeng ^a   Wang, Jiwen ^a   Sun, Jian ^a   Hang, Jie ^a   Shi, Susheng ^a   Feng, Xiaoli ^a   He, Fuchu ^b   He, Jie ^a   more..

^a PEKING UNION MEDICAL COLLEGE   (China)

^b BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ISOCITRATE DEHYDROGENASE; ISOCITRATE DEHYDROGENASE 1; MANGANESE SUPEROXIDE DISMUTASE; PEROXIREDOXIN 2; PROTEIN 14 3 3; PROTEIN 14 3 3 EPSILON; RECEPTOR FOR ACTIVATED C KINASE 1; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; IDH1 PROTEIN, HUMAN; MESSENGER RNA; PROTEOME; TUMOR MARKER;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING; ADENOCARCINOMA; ANIMAL; BRONCHUS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; ENZYME IMMUNOASSAY; GENETICS; LUNG; LUNG TUMOR; MASS SPECTROMETRY; METABOLISM; MIDDLE AGED; MORTALITY; NUDE MOUSE; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADENOCARCINOMA; ADULT; AGED; ANIMALS; BLOTTING, WESTERN; BRONCHI; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; ISOCITRATE DEHYDROGENASE; LUNG; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; MIDDLE AGED; PROGNOSIS; PROTEOME; PROTEOMICS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84863053122     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M111.008821     Document Type: Article

References (55)

1. Jemal, A., Siegel, R., Xu, J., and Ward, E. (2010) Cancer statistics. CA-Cancer J. Clin. 60, 277-300
2. Hoffman, P. C., Mauer, A. M., and Vokes, E. E. (2000) Lung cancer. Lancet. 355, 479-485 (Pubitemid 30085163)
3. Simpson, R. J., Bernhard, O. K., Greening, D. W., and Moritz, R. L. (2008) Proteomics-driven cancer biomarker discovery: Looking to the future. Curr. Opin. Chem. Biol. 12, 72-77
4. Cho, W. C., and Cheng, C. H. (2007) Oncoproteomics: Current trends and future perspectives. Exp. Rev. Proteomics 4, 401-410 (Pubitemid 46890077)
5. Li, C., Xiao, Z., Chen, Z., Zhang, X., Li, J., Wu, X., Li, X., Yi, H., Li, M., Zhu, G., and Liang, S. (2006) Proteome analysis of human lung squamous carcinoma. Proteomics 6, 547-558 (Pubitemid 43208034)
6. Huang, L. J., Chen, S. X., Luo, W. J., Jiang, H. H., Zhang, P. F., and Yi, H. (2006) Proteomic analysis of secreted proteins of non-small cell lung cancer. Chin. J. Cancer 25, 1361-1367
7. Maciel, C. M., Junqueira, M., Paschoal, M. E., Kawamura, M. T., Duarte, R. L., Carvalho Mda, G., and Domont, G. B. (2005) Differential proteomic serum pattern of low molecular weight proteins expressed by adenocarcinoma lung cancer patients. J. Exp. Ther. Oncol. 5, 31-38 (Pubitemid 41076988)
8. Li, C., Chen, Z., Xiao, Z., Wu, X., Zhan, X., Zhang, X., Li, M., Li, J., Feng, X., Liang, S., Chen, P., and Xie, J. Y. (2003) Comparative proteomics analysis of human lung squamous carcinoma. Biochem. Biophys. Res. Commun. 309, 253-260 (Pubitemid 36999783)
9. Deng, B., Ye, N., Luo, G., Chen, X., and Wang, Y. (2005) Proteomics analysis of stage-specific proteins expressed in human squamous cell lung carcinoma tissues. Cancer Biomark. 1, 279-286
10. Li, C., Zhan, X., Li, M., Wu, X., Li, F., Li, J., Xiao, Z., Chen, Z., Feng, X., Chen, P., Xie, J., and Liang, S. (2003) Proteomic comparison of two-dimensional gel electrophoresis profiles from human lung squamous carcinoma and normal bronchial epithelial tissues. Genomics Proteomics Bioinformatics 1, 58-67
11. Wu, X., Xiao, Z., Chen, Z., Li, C., Li, J., Feng, X., Yi, H., Liang, S., and Chen, P. (2004) Differential analysis of two-dimension gel electrophoresis profiles from the normal-metaplasia-dysplasia-carcinoma tissue of human bronchial epithelium. Pathol. Int. 54, 765-773 (Pubitemid 39452408)
12. Chen, G., Gharib, T. G., Wang, H., Huang, C. C., Kuick, R., Thomas, D. G., Shedden, K. A., Misek, D. E., Taylor, J. M., Giordano, T. J., Kardia, S. L., Iannettoni, M. D., Yee, J., Hogg, P. J., Orringer, M. B., Hanash, S. M., and Beer, D. G. (2003) Protein profiles associated with survival in lung adenocarcinoma. Proc. Natl. Acad. Sci. U.S.A. 100, 13537-13542 (Pubitemid 37444777)
13. Chen, G., Gharib, T. G., Huang, C. C., Thomas, D. G., Shedden, K. A., Taylor, J. M., Kardia, S. L., Misek, D. E., Giordano, T. J., Iannettoni, M. D., Orringer, M. B., Hanash, S. M., and Beer, D. G. (2002) Proteomic analysis of lung adenocarcinoma: Identification of a highly expressed set of proteins in tumors. Clin. Cancer Res. 8, 2298-2305 (Pubitemid 34753604)
14. Li, R., Wang, H., Bekele, B. N., Yin, Z., Caraway, N. P., Katz, R. L., Stass, S. A., and Jiang, F. (2006) Identification of putative oncogenes in lung adenocarcinoma by a comprehensive functional genomic approach. Oncogene 25, 2628-2635
15. Seike, M., Kondo, T., Fujii, K., Yamada, T., Gemma, A., Kudoh, S., and Hirohashi, S. (2004) Proteomic signature of human cancer cells. Proteomics 4, 2776-2788 (Pubitemid 39202177)
16. Seike, M., Kondo, T., Fujii, K., Okano, T., Yamada, T., Matsuno, Y., Gemma, A., Kudoh, S., and Hirohashi, S. (2005) Proteomic signatures for histological types of lung cancer. Proteomics 5, 2939-2948 (Pubitemid 41059770)
17. Poschmann, G., Sitek, B., Sipos, B., Ulrich, A., Wiese, S., Stephan, C., Warscheid, B., Klöppel, G., Vander Borght, A., Ramaekers, F. C., Meyer, H. E., and Stühler, K. (2009) Identification of proteomic differences between squamous cell carcinoma of the lung and bronchial epithelium. Mol. Cell. Proteomics 8, 1105-1116
18. Bührens, R. I., Amelung, J. T., Reymond, M. A., and Beshay, M. (2009) Protein expression in human non-small cell lung cancer: A systematic database. Pathobiology 76, 277-285
19. Trachootham, D., Alexandre, J., and Huang, P. (2009) Targeting cancer cells by ROS-mediated mechanisms: A radical therapeutic approach? Nat. Rev. 8, 579-591
20. Acharya, A., Das, I., Chandhok, D., and Saha, T. (2010) Redox regulation in cancer: A double-edged sword with therapeutic potential. Oxid. Med. Cel. Longev. 3, 23-34
21. Obsilova, V., Silhan, J., Boura, E., Teisinger, J., and Obsil, T. (2008) 14-3-3 proteins: A family of versatile molecular regulators. Physiol. Res. 3, (57 Suppl.) S11-S21
22. Osada, H., Tatematsu, Y., Yatabe, Y., Nakagawa, T., Konishi, H., Harano, T., Tezel, E., Takada, M., and Takahashi, T. (2002) Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers. Oncogene 21, 2418-2424 (Pubitemid 34407301)
23. Fan, T., Li, R., Todd, N. W., Qiu, Q., Fang, H. B., Wang, H., Shen, J., Zhao, R. Y., Caraway, N. P., Katz, R. L., Stass, S. A., and Jiang, F. (2007) Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res. 67, 7901-7906 (Pubitemid 47281386)
24. Besson, A., Wilson, T. L., and Yong, V. W. (2002) The anchoring protein RACK1 links protein kinase Cepsilon to integrin beta chains: Requirements for adhesion and motility. J. Biol. Chem. 277, 22073-22084 (Pubitemid 34952362)
25. Steele, M. R., McCahill, A., Thompson, D. S., MacKenzie, C., Isaacs, N. W., Houslay, M. D., and Bolger, G. B. (2001) Identification of a surface on the beta-propeller protein RACK1 that interacts with the cAMP-specific phosphodiesterase PDE4D5. Cell. Signal. 13, 507-513 (Pubitemid 32545452)
26. Chang, B. Y., Chiang, M., and Cartwright, C. A. (2001) The interaction of Src and RACK1 is enhanced by activation of protein kinase C and tyrosine phosphorylation of RACK1. J. Biol. Chem. 276, 20346-20356
27. Wang, Z., Jiang, L., Huang, C., Li, Z., Chen, L., Gou, L., Chen, P., Tong, A., Tang, M., Gao, F., Shen, J., Zhang, Y., Bai, J., Zhou, M., Miao, D., and Chen, Q. (2008) Comparative proteomics approach to screening of potential diagnostic and therapeutic targets for oral squamous cell carcinoma. Mol. Cell. Proteomics 7, 1639-1650
28. Wang, Z., Zhang, B., Jiang, L., Zeng, X., Chen, Y., Feng, X., Guo, Y., and Chen, Q. (2009) RACK1, an excellent predictor for poor clinical outcome in oral squamous carcinoma, similar to Ki67. Eur. J. Cancer 45, 490-496
29. Egidy, G., Julé, S., Bossé, P., Bernex, F., Geffrotin, C., Vincent-Naulleau, S., Horak, V., Sastre-Garau, X., and Panthier, J. J. (2008) Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferation. Mol. Cancer 7, 34
30. Cao, X. X., Xu, J. D., Liu, X. L., Xu, J. W., Wang, W. J., Li, Q. Q., Chen, Q., Xu, Z. D., and Liu, X. P. (2010) RACK1: A superior independent predictor for poor clinical outcome in breast cancer. Int. J. Cancer 127, 1172-1179
31. Nagashio, R., Sato, Y., Matsumoto, T., Kageyama, T., Satoh, Y., Shinichiro, R., Masuda, N., Goshima, N., Jiang, S. X., and Okayasu, I. (2010) Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas. Lung Cancer 69, 54-59
32. Wu, W. S. (2006) The signaling mechanism of ROS in tumor progression. Cancer Metastasis Rev. 25, 695-705
33. Yan, T., Oberley, L. W., Zhong, W., and St Clair, D. K. (1996) Manganese-containing superoxide dismutase overexpression causes phenotypic reversion in SV40-transformed human lung fibroblasts. Cancer Res. 56, 2864-2871 (Pubitemid 26175749)
34. Zhong, W., Oberley, L. W., Oberley, T. D., Yan, T., Domann, F. E., and St Clair, D. K. (1996) Inhibition of cell growth and sensitization to oxidative damage by overexpression of manganese superoxide dismutase in rat glioma cells. Cell Growth Differ. 7, 1175-1186 (Pubitemid 26360698)
35. Cullen, J. J., Weydert, C., Hinkhouse, M. M., Ritchie, J., Domann, F. E., Spitz, D., and Oberley, L. W. (2003) The role of manganese superoxide dismutase in the growth of pancreatic adenocarcinoma. Cancer Res. 63, 1297-1303 (Pubitemid 36348708)
36. Ough, M., Lewis, A., Zhang, Y., Hinkhouse, M. M., Ritchie, J. M., Oberley, L. W., and Cullen, J. J. (2004) Inhibition of cell growth by overexpression of manganese superoxide dismutase (MnSOD) in human pancreatic carcinoma. Free Radic. Res. 38, 1223-1233 (Pubitemid 39654512)
37. Izutani, R., Asano, S., Imano, M., Kuroda, D., Kato, M., and Ohyanagi, H. (1998) Expression of manganese superoxide dismutase in esophageal and gastric cancers. J. Gastroenterol. 33, 816-822 (Pubitemid 29271542)
38. Kim, J. J., Chae, S. W., Hur, G. C., Cho, S. J., Kim, M. K., Choi, J., Nam, S. Y., Kim, W. H., Yang, H. K., and Lee, B. L. (2002) Manganese superoxide dismutase expression correlates with a poor prognosis in gastric cancer. Pathobiology 70, 353-360 (Pubitemid 36829011)
39. Janssen, A. M., Bosman, C. B., Sier, C. F., Griffioen, G., Kubben, F. J., Lamers, C. B., van Krieken, J. H., van de Velde, C. J., and Verspaget, H. W. (1998) Superoxide dismutases in relation to the overall survival of colorectal cancer patients. Br. J. Cancer 78, 1051-1057 (Pubitemid 28463981)
40. Haapasalo, H., Kyläniemi, M., Paunul, N., Kinnula, V. L., and Soini, Y. (2003) Expression of antioxidant enzymes in astrocytic brain tumors. Brain Pathol. 13, 155-164 (Pubitemid 36460816)
41. Chung-man Ho, J., Zheng, S., Comhair, S. A., Farver, C., and Erzurum, S. C. (2001) Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res. 61, 8578-8585
42. Yang, F., Xiao, Z. Q., Zhang, X. Z., Li, C., Zhang, P. F., Li, M. Y., Chen, Y., Zhu, G. Q., Sun, Y., Liu, Y. F., and Chen, Z. C. (2007) Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis. J. Proteome Res. 6, 751-758 (Pubitemid 46340178)
43. Des Rosiers, C., Di Donato, L., Comte, B., Laplante, A., Marcoux, C., David, F., Fernandez, C. A., and Brunengraber, H. (1995) Isotopomer analysis of citric acid cycle and gluconeogenesis in rat liver: Reversibility of isocitrate dehydrogenase and involvement of ATP-citrate lyase in gluconeogenesis. J. Biol. Chem. 270, 10027-10036
44. DeBerardinis, R. J., Lum, J. J., Hatzivassiliou, G., and Thompson, C. B. (2008) The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 57, 11-20
45. Ronnebaum, S. M., Ilkayeva, O., Burgess, S. C., Joseph, J. W., Lu, D., Stevens, R. D., Becker, T. C., Sherry, A. D., Newgard, C. B., and Jensen, M. V. (2006) A pyruvate cycling pathway involving cytosolic NADP-dependent isocitrate dehydrogenase regulates glucose-stimulated insulin secretion. J. Biol. Chem. 281, 30593-30602 (Pubitemid 44582115)
46. Holmgren, A. (2000) Antioxidant function of thioredoxin and glutaredoxin systems. Antioxid. Redox Signal. 2, 811-820
47. Park, J. H., Kim, Y. S., Lee, H. L., Shim, J. Y., Lee, K. S., Oh, Y. J., Shin, S. S., Choi, Y. H., Park, K. J., Park, R. W., and Hwang, S. C. (2006) Expression of peroxiredoxin and thioredoxin in human lung cancer and paired normal lung. Respirology 11, 269-275
48. Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., Rabinowitz, J. D., Carroll, M., Su, S. M., Sharp, K. A., Levine, R. L., and Thompson, C. B. (2010) The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 17, 225-234
49. Kil, I. S., Huh, T. L., Lee, Y. S., Lee, Y. M., and Park, J. W. (2006) Regulation of replicative senescence by NADP+-dependent isocitrate dehydrogenase. Free Radic. Biol. Med. 40, 110-119 (Pubitemid 41759408)
50. Bleeker, F. E., Lamba, S., Leenstra, S., Troost, D., Hulsebos, T., Vandertop, W. P., Frattini, M., Molinari, F., Knowles, M., Cerrato, A., Rodolfo, M., Scarpa, A., Felicioni, L., Buttitta, F., Malatesta, S., Marchetti, A., and Bardelli, A. (2009) IDH1 mutations at residue p.R132 (IDH1(R132)) occur frequently in high-grade gliomas but not in other solid tumors. Hum. Mutat. 30, 7-11
51. Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., Friedman, H., Friedman, A., Reardon, D., Herndon, J., Kinzler, K. W., Velculescu, V. E., Vogelstein, B., and Bigner, D. D. (2009) IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765-773
52. Zhao, S., Lin, Y., Xu, W., Jiang, W., Zha, Z., Wang, P., Yu, W., Li, Z., Gong, L., Peng, Y., Ding, J., Lei, Q., Guan, K. L., and Xiong, Y. (2009) Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science 324, 261-265
53. Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., Marks, K. M., Prins, R. M., Ward, P. S., Yen, K. E., Liau, L. M., Rabinowitz, J. D., Cantley, L. C., Thompson, C. B., Vander Heiden, M. G., and Su, S. M. (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462, 739-744
54. Mardis, E. R., Ding, L., Dooling, D. J., Larson, D. E., McLellan, M. D., Chen, K., Koboldt, D. C., Fulton, R. S., Delehaunty, K. D., McGrath, S. D., Fulton, L. A., Locke, D. P., Magrini, V. J., Abbott, R. M., Vickery, T. L., Reed, J. S., Robinson, J. S., Wylie, T., Smith, S. M., Carmichael, L., Eldred, J. M., Harris, C. C., Walker, J., Peck, J. B., Du, F., Dukes, A. F., Sanderson, G. E., Brummett, A. M., Clark, E., McMichael, J. F., Meyer, R. J., Schindler, J. K., Pohl, C. S., Wallis, J. W., Shi, X., Lin, L., Schmidt, H., Tang, Y., Haipek, C., Wiechert, M. E., Ivy, J. V., Kalicki, J., Elliott, G., Ries, R. E., Payton, J. E., Westervelt, P., Tomasson, M. H., Watson, M. A., Baty, J., Heath, S., Shannon, W. D., Nagarajan, R., Link, D. C., Walter, M. J., Graubert, T. A., DiPersio, J. F., Wilson, R. K., and Ley, T. J. (2009) Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058-1066
55. Kang, M. R., Kim, M. S., Oh, J. E., Kim, Y. R., Song, S. Y., Seo, S. I., Lee, J. Y., Yoo, N. J., and Lee, S. H. (2009) Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int. J. Cancer 125, 353-355